Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00247416
Status:
COMPLETED
Last Update Posted:
2014-03-07
First Post:
2005-10-28
Brief Title:
Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer
Sponsor:
Susanne Arnold
Organization:
University of Kentucky
Study Overview
Official Title:
Randomized Phase II Trail of Carboplatin and Gemcitabine Untreated Stage IIIB-pleural Effusion and Stage IV Lung Cancer
Status:
COMPLETED
Status Verified Date:
2014-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to find better treatment for lung cancer and to find out what effects the combined treatment of carboplatin and gemcitabine when given with or without dexamethasone have on cancer
This study will determine if dexamethasone when given before standard chemotherapy will increase the cancer fighting effects and reduce the side effects of chemotherapy
This study will determine if dexamethasone when given before standard chemotherapy will increase the cancer fighting effects and reduce the side effects of chemotherapy
Detailed Description:
Subjects enrolled in the study will be placed in one of two treatment arms All subjects have a 50-50 chance of being placed into either treatment arm Treatment Arm 1 will receive chemotherapy alone Treatment Arm 2 will receive chemotherapy with dexamethasone given pre-treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None